UPXI.NASDAQUpexi, INC

10-Q: Upexi Shifts to Solana, Reports Massive Q2 Loss Amid Digital Asset Volatility

Sentiment:

Quarterly Report


Upexi, Inc. reported a significant net loss of $178.9 million for Q2 2026, driven by unrealized losses on its substantial Solana digital asset treasury, despite a strategic pivot to cryptocurrency and staking.

Capital raiseIssued 12,457,186 shares of common stock in a private placement offering in July 2025.Issued 3,289,474 shares of common stock and accompanying warrants for an aggregate purchase price of $10,000,000 in a private placement offering in November 2025.Subsequent to the reporting period, in February 2026, closed a registered direct offering for 6,337,000 shares of common stock and warrants to purchase up to 6,337,000 shares at a combined offering price of $1.17 per unit.The company has a shelf registration statement on file with the SEC, declared effective January 8, 2026, for future offerings.
Worse than expectedNet loss for the three months ended December 31, 2025, was $(178,924,930), significantly worse than the $(1,301,310) loss in the prior year.The substantial increase in net loss was primarily driven by $164,495,019 in unrealized losses on digital assets, which did not exist in the prior period.Traditional product revenue declined by 27.4% for the quarter, indicating a significant downturn in the legacy business.Gross margin decreased by 20% for the quarter, mainly due to inventory valuation adjustments.General and administrative expenses increased by 257% for the quarter, contributing to higher operating losses.

Summary

  • Upexi, Inc. has significantly shifted its business strategy to focus on the cryptocurrency industry, specifically holding and staking Solana (SOL) tokens, moving away from its traditional consumer products business.
  • The company reported a net loss of $178.9 million for the three months ended December 31, 2025, a substantial increase from a $1.3 million net loss in the prior year period.
  • This loss was primarily driven by $164.5 million in unrealized losses on digital assets due to SOL price changes, and increased stock-based compensation of $8.3 million.
  • Total revenue for the quarter increased by 101% to $8.05 million, largely due to $5.1 million in new digital asset staking revenue.
  • Traditional product revenue declined by 27.4% to $2.9 million, with management not expecting significant increases in these revenue sources in future quarters.
  • The company holds 2,173,204 Solana tokens with a fair value of $255.7 million as of December 31, 2025, with approximately 95% of its treasury staked.
  • Upexi is exiting certain manufacturing and distribution operations related to hemp-ingredient health and wellness products, incurring a $1.4 million impairment loss.
  • The company raised capital through private placements in July and November 2025, and a subsequent registered direct offering in February 2026, to fund its digital asset strategy.
  • Material weaknesses in internal controls over financial reporting were identified, including inadequate segregation of duties and lack of multiple levels of supervision and review.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a highly speculative and high-risk filing. While the company has successfully pivoted to a digital asset strategy and raised significant capital, the massive net loss driven by unrealized digital asset losses and the ongoing legal disputes create substantial uncertainty and financial instability.

Positives

  • Successful pivot into the digital asset space, generating $5.1 million in digital asset revenue for the quarter and $11.2 million for the six months ended December 31, 2025.
  • Significant growth in digital asset holdings, with Solana tokens increasing from 744,026 to 2,173,204 and fair value growing from $106.0 million to $255.7 million over six months.
  • Approximately 95% of the Solana treasury is staked, generating yield and turning the treasury into a productive asset.
  • Ability to acquire locked Solana at a 14% discount to market value, providing potential for higher gains as the discount narrows.
  • Successful capital raises through private placements and a registered direct offering, demonstrating investor interest in the new digital asset strategy.
  • Initiated a $50 million share repurchase program, signaling confidence in future value.

Negatives

  • Massive net loss of $178.9 million for the three months ended December 31, 2025, primarily due to $164.5 million in unrealized losses on digital assets.
  • Traditional product revenue declined by 27.4% for the quarter and 27.5% for the six months, indicating a struggling legacy business.
  • Gross margin decreased by 20% for the quarter (from 74.3% to 53.9%) and 8% for the six months (from 70.6% to 62.1%), mainly due to inventory valuation adjustments.
  • Significant increase in general and administrative expenses (257% for the quarter, 407% for six months) due to public company expenses, professional fees, digital asset treasury fees, and compensation.
  • Substantial increase in debt, with convertible notes payable reaching $144.1 million and short-term treasury debt at $62.7 million, primarily for digital asset purchases.
  • Cash balance decreased from $2.98 million to $1.62 million over six months.
  • Impairment loss of $1.42 million due to the shutdown of certain manufacturing and distribution operations.
  • Termination of the Asset Management Agreement by GSR Strategies LLC, leading to arbitration and potential early termination fees or damages.

Risks

  • Substantial market volatility, evolving regulatory frameworks, liquidity constraints, cybersecurity threats, and technological risks associated with cryptocurrency holdings.
  • Uncertainty and differing interpretations of Farm Bill-compliant hemp programs and cannabinoid regulation, which may adversely affect product introduction in different markets.
  • Risk of potential dilution from fractional shares issued during the reverse stock split, despite shares being returned to the transfer agent, as it is subject to a pending lawsuit.
  • Material weaknesses in internal control over financial reporting, including inadequate segregation of duties and lack of multiple levels of supervision and review, which could lead to material misstatements.
  • Liquidity risks associated with the staking program, as staked SOL is inaccessible for a cooldown period (typically up to two days) during unstaking.
  • Risk of choosing validators with poor performance in the staking program, leading to low staking yield, although Solana does not implement slashing penalties.
  • Dependence on third-party qualified custodians for digital asset storage, introducing counterparty risk despite multiple custodians and insurance.
  • Legal proceedings, including arbitration with GSR Strategies LLC, a fraud lawsuit related to the Infusionz acquisition, a trade-dress lawsuit, and disputes over alleged unpaid amounts and fraudulent inducement.
  • The convertible notes cannot be repaid in cash and can only be converted into common stock or repaid with SOL tokens at maturity, exposing the company to SOL price fluctuations.

Future Outlook

Management will focus its resources on the digital asset strategy, with a significant portion of the balance sheet allocated to holding Solana in the Company's digital asset treasury. Digital asset revenue is expected to increase as the number of SOL tokens staked increases, the overall price of SOL rises, and the Company continues to expand its digital asset strategy. Traditional product revenue is not expected to see significant increases. The company estimates sufficient working capital for the next twelve months and has an effective shelf registration for future offerings.

Management Comments

  • "Management will focus its resources to this digital asset strategy, and a significant portion of the balance sheet will be the Company's Solana digital asset treasury."
  • "Currently our treasury is exclusively dedicated to the SOL digital asset and currently we do not intend to dedicate any of the treasury allocated capital to other digital assets."
  • "We will stake the vast majority of the Solana in our treasury to earn a staking yield and turn the treasury into a productive asset."
  • "We do not hedge our SOL and do not have plans to hedge our SOL in the future."
  • "We plan to utilize intelligent capital markets issuance including the issuance of both equity and convertible debt where we may issue capital in an accretive fashion for the benefit of shareholders to purchase and hold more Solana."
  • "We believe the weaknesses [in internal controls] and their related risks are not uncommon in a company of our size because of the limitations in the size and number of staff."
  • "We estimate that we will have sufficient working capital to fund our operations over the twelve months following the date of the issuance of these condensed consolidated financial statements and meet all of our debt obligations."

Industry Context

StockSavvy.ai notes that Upexi's aggressive pivot into Solana-focused digital asset management and staking aligns with a growing trend among some companies to integrate cryptocurrency into treasury strategies, seeking higher yields and exposure to emerging blockchain ecosystems. This strategy, while potentially offering significant upside in a bull market, also exposes the company to the extreme volatility and regulatory uncertainties inherent in the digital asset space, a risk many traditional companies avoid. The focus on Solana, a high-performance blockchain, positions Upexi within a segment of the crypto market known for its speed and scalability, attracting a vibrant developer ecosystem.

Comparison to Industry Standards

  • Upexi's strategy of holding a significant portion of its treasury in a single volatile digital asset like Solana is highly unconventional compared to traditional corporate treasury management, which typically prioritizes liquidity and capital preservation in stable assets like cash, short-term government bonds, or highly-rated corporate debt.
  • Companies like MicroStrategy, which has famously adopted a Bitcoin treasury strategy, represent a rare precedent for public companies holding substantial digital assets. However, MicroStrategy's focus is on Bitcoin, a more established cryptocurrency, whereas Upexi's exclusive focus on Solana, described as "earlier in its lifecycle," implies a higher risk tolerance.
  • The 11.5% interest rate on the BitGo Credit Facility for digital asset purchases is significantly higher than typical corporate borrowing rates, reflecting the elevated risk associated with crypto-backed loans. For instance, a well-established company might secure a credit facility at prime rate plus a spread (e.g., 5-8%), highlighting the premium Upexi pays for its crypto-centric financing.
  • The reported gross margin of 53.9% for the three months ended December 31, 2025, for its traditional product business, while a decrease from 74.3% in the prior year, is still relatively healthy for a consumer products company, though the declining revenue in this segment is a concern.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control DeficienciesIdentified material weaknesses in internal control over financial reporting, including inadequate segregation of duties and lack of multiple levels of supervision and review.December 31, 2025Increases risk of material misstatement in financial statements; remediation planned by end of FY2026.
Phantom Stock Appreciation PlanApproved the Upexi, Inc. Phantom Stock Appreciation Plan to motivate and reward key employees with incentive compensation based on company value increase, paid in cash.July 1, 2025Introduces a new liability-classified compensation scheme, impacting accrued compensation and general and administrative expenses.
Share Repurchase ProgramBoard of Directors authorized a share repurchase program of up to $50 million of common stock.November 2025Aims to return value to shareholders and potentially support share price, but timing and amount are at management's discretion.

Legal Proceedings

  • Upexi, Inc. v. GSR Strategies LLC: Arbitration filed by Upexi on November 26, 2025, disputing GSR's termination of the Asset Management Agreement and seeking declaratory judgments. GSR filed counterclaims for damages.
  • Bloomios, Inc., Infused Confections, LLC and Infusionz, LLC v. The Company et al.: Action filed around April 7, 2025, alleging fraud, misrepresentation, and breach of contract related to the October 2022 acquisition of Infusionz. Company considers it baseless and filed counterclaims for approximately $19.5 million.
  • MVW Holdings v. E-Core Technology, Inc. and The Company: Trade-dress lawsuit filed December 20, 2024, despite E-Core no longer being owned by the Company.
  • Eric Hanig v. The Company and Cygnet Online, LLC: Lawsuit filed September 6, 2024, for alleged failure to pay $300,000. Company denies claims and filed counterclaims for fraudulent inducement and absconding with bank account balance.
  • Get Fit Fast Supplements, LLC v. Cygnet Online, LLC, et al.: Arbitration filed March 14, 2024, concerning breach of contract and fraud related to the acquisition of Cygnet Online, LLC and Get Fit Fast Supplements, LLC. Company is not a party but is defending Cygnet. Decision anticipated March 2026.

Related Party Transactions

  • In March 2025, Allan Marshall (CEO) purchased 125,000 Series A preferred shares from the Company by cancelling a $400,000 related party advance.
  • On April 1, 2024, the Company entered into a lease agreement with MFA 2510 Merchant LLC, an entity owned by CEO Allan Marshall, for warehouse and office space at $20,060 per month.
  • On June 13, 2024, Allan Marshall (CEO) was one of three investors who purchased VitaMedica, Inc. from the Company, with $2,000,000 of the purchase price remaining receivable as of December 31, 2025.

Stakeholder Impact

  • Shareholders: Significant dilution from recent equity issuances, massive net loss impacting equity, but potential upside from the digital asset strategy if SOL price appreciates. Share repurchase program could provide some support.
  • Employees: Phantom Stock Appreciation Plan offers incentive compensation. Exit of manufacturing operations may lead to job losses in those specific centers.
  • Customers: Traditional product customers may experience changes due to the shift in focus and exit of certain product lines.
  • Creditors: Increased debt levels, particularly convertible notes and the BitGo credit facility, increase financial risk. The ability to repay convertible notes with SOL tokens introduces cryptocurrency price risk for noteholders.
  • Regulatory Authorities: Identified material weaknesses in internal controls could attract increased scrutiny.

Next Steps

  • Complete the exit of certain manufacturing and distribution operations by February 15, 2026.
  • Remediate identified material weaknesses in internal controls over financial reporting by the end of fiscal year 2026.
  • Vigorously prosecute claims and defend against counterclaims in the arbitration with GSR Strategies LLC.
  • Continue to defend against lawsuits from Bloomios, Inc. et al., MVW Holdings, and Eric Hanig.
  • Anticipate a decision in the Get Fit Fast Supplements, LLC arbitration in March 2026.
  • Continue to monitor and evaluate the effectiveness of internal controls and procedures.
  • Expand to additional qualified custodians for digital asset storage as the treasury grows.
  • Utilize proceeds from future offerings for corporate purposes or other disclosed purposes.

Key Dates

DateDescription
2018Company originally formed as a Nevada corporation.
March 15, 2023Company entered a lease for 20,400 sq ft warehouse and office space in Tampa, FL.
July 2023Company moved into the Tampa warehouse facility and started operations.
July 25, 2023Company entered a lease for 5,700 sq ft office space in Tampa, FL for corporate headquarters.
March 14, 2024Get Fit Fast Supplements, LLC filed for arbitration against Cygnet Online, LLC, and Eric Hanig.
April 1, 2024Company entered into a lease agreement with MFA 2510 Merchant LLC (owned by CEO Allan Marshall) for 10,000 sq ft warehouse/office space in Odessa, FL.
June 13, 2024Company sold 100% equity of VitaMedica, Inc. to three investors, including CEO Allan Marshall.
August 1, 2024Product manufacturing fully moved from Nevada facility to Odessa, FL facility.
September 6, 2024Eric Hanig filed suit against the Company and Cygnet Online, LLC.
September 18, 2024Company filed a Certificate of Change for a 1-for-20 reverse stock split.
October 3, 2024Effective date of the 1-for-20 reverse stock split.
October 23, 2024202,183 shares of common stock issued for fractional share round-ups post-reverse split.
October 30, 2024Company notified that 202,183 shares issued for fractional round-ups were returned to transfer agent.
December 20, 2024MVW Holdings filed a lawsuit against E-Core Technology, Inc. and the Company.
January 1, 2025Company first held digital assets, effective date for early adoption of ASU 2023-08.
March 2025CEO Allan Marshall purchased 125,000 Series A preferred shares by cancelling a $400,000 related party advance.
April 7, 2025Bloomios, Inc. et al. filed an action against the Company and its executive officers and directors.
April 23, 2025Company entered into an Asset Management Agreement with GSR Strategies LLC.
May 1, 2025Company entered into a Custodial Services Agreement with BitGo Trust Company, Inc.
May 5, 2025Company entered into an Institutional Client Agreement with Coinbase Inc.
July 1, 2025Board of Directors approved the Upexi, Inc. Phantom Stock Appreciation Plan.
July 2025Company issued 12,457,186 shares of common stock in a private placement offering.
July 16, 2025Company entered into securities purchase agreements for secured convertible notes in exchange for locked and spot Solana.
August 28, 2025Company entered into an agreement with Cybersyn Holdings, LLC to acquire a 14.9% contractual royalty interest.
October 27, 2025Asset Manager (GSR Strategies LLC) provided notice of belief that the Company defaulted under the Asset Management Agreement.
November 2025Company's Board of Directors authorized a share repurchase program of up to $50M of common stock.
November 13, 2025Company announced a program to repurchase up to $50.0 million of its own common stock.
November 26, 2025Company issued 3,289,474 shares of common stock and warrants in a private placement offering for $10,000,000.
November 26, 2025Company filed an Arbitration Demand against GSR Strategies LLC.
December 2025Company repurchased 416,226 shares of common stock at an average price of $1.94.
December 26, 2025Asset Management Agreement with GSR Strategies LLC terminated by GSR.
December 30, 2025GSR Strategies LLC filed counterclaims in the arbitration against Upexi.
December 31, 2025End of the reporting period for this 10-Q. Company decided to shut down certain manufacturing and distribution centers.
January 8, 2026Shelf registration statement with the SEC declared effective.
January 9, 2026Company entered into a secured convertible note for approximately $36 million in exchange for 265,500 units of locked Solana.
February 9, 2026Registrant had 69,760,581 shares of common stock issued.
February 10, 2026Date of filing of this Form 10-Q.
February 15, 2026Expected completion date for the shutdown of certain manufacturing and distribution centers.
February 2026Company closed a registered direct offering of 6,337,000 shares of common stock and warrants.
March 2026Decision anticipated for the Get Fit Fast Supplements, LLC arbitration.
June 1, 2026Maturity date for Promissory Notes.
June 30, 2026Expected recognition of 100% of deferred revenue; 434,153 locked Solana tokens unlock.
July 16, 2027Maturity date for convertible notes issued in July 2025.
June 30, 2027Maturity date for Inventory consignment note; 389,654 locked Solana tokens unlock.
November 7, 2026Maturity date for GF Note.
June 30, 202827,000 locked Solana tokens unlock.
January 9, 2028Maturity date for convertible note issued in January 2026.
October 6, 2051Maturity date for SBA note payable.

Recommendation

strong sell

The company's financial performance is severely impacted by a massive net loss, primarily due to unrealized losses on its highly volatile digital asset holdings. While the strategic pivot to Solana and staking offers potential long-term upside, the immediate financial results are alarming, coupled with declining traditional revenue, increasing debt, and identified material weaknesses in internal controls. The ongoing legal disputes and the inherent risks of cryptocurrency market volatility further compound the uncertainty, making this a high-risk investment with significant downside potential in the short to medium term.

Keywords

Solana, cryptocurrency, digital assets, staking, blockchain, SEC filing, 10-Q, financial results, net loss, treasury strategy, consumer products, impairment, capital raise, convertible notes, BitGo, GSR Strategies, internal controls, legal proceedings, UPXI

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.